Starcad-Beta 25 Tablet ER
Marketer
Lupin Ltd
Salt Composition
S-Metoprolol Succinate (23.75mg)
Overview Starcad-Beta 25 Tablet ER
Betapace ER 25mg extended-release tablets are classified as beta-adrenergic blocking agents. This medication treats hypertension (high blood pressure), angina pectoris (chest pain from heart disease), and cardiac arrhythmias (irregular heartbeats). It also helps prevent future strokes, heart attacks, and migraine episodes. Additionally, it alleviates symptoms associated with hyperthyroidism. Prescribed individually or in combination with other drugs, dosage and frequency are tailored to the specific condition and its severity. Consumption with or without food is acceptable; however, consistent daily timing maximizes effectiveness. Full therapeutic benefit may take weeks to manifest, potentially requiring lifelong use. Continued use is crucial even during symptom remission, as hypertension often presents asymptomatically, and discontinuation may exacerbate the condition. Common side effects, typically mild and transient, include tiredness, bradycardia (slow heart rate), dizziness, constipation, and peripheral vasoconstriction (cold extremities). Less frequently, shortness of breath or hypotension (low blood pressure) can occur. To minimize adverse reactions, initial dosages are typically low, gradually increasing as tolerated. Report any persistent or bothersome side effects to your physician. Prior to initiating treatment, disclose any hepatic impairment (liver problems). This medication is contraindicated for individuals with bradycardia, severe peripheral vascular disease, decompensated heart failure, or hypotension. Pregnant or lactating individuals should seek medical advice before use. Always consult your physician to determine suitability. Regular blood pressure monitoring ensures treatment efficacy. Alcohol consumption should be limited due to potential exacerbation of side effects.
Uses of Starcad-Beta 25 Tablet ER
Managing high blood pressure | Alleviating angina pectoris | Cardiac arrhythmia management | Heart attack prophylaxis | Stroke prevention | Migraine prevention
Major Benefits of Starcad-Beta 25 Tablet ER:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Starcad-Beta 25 Extended-Release Tablet can be consumed with or without food; however, consistent daily timing is recommended.
Common Side effects of Starcad-Beta 25 Tablet ER:
- Fatigue
- Slow heart rate
- Constipation
- Diarrhea
- Dizziness
- Cold extremities
How to use Starcad-Beta 25 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the Starcad-Beta 25 Tablet ER whole; avoid chewing, crushing, or breaking it. This extended-release tablet can be administered with or without food, however, consistent timing is recommended.
How Starcad-Beta 25 Tablet ER works:
Extended-release Starcad-Beta 25 tablets are a cardioselective beta-blocker, reducing heart rate and improving the heart's pumping efficiency for better circulatory function.
SAFETY ADVICE
AlcoholUNSAFE
Combining Starcad-Beta 25 Tablet ER and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Starcad-Beta 25 Extended-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Starcad-Beta 25 tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer via breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Starcad-Beta 25 Tablet ER on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Extended-release Starcad-Beta 25 tablets are likely safe for individuals with kidney impairment. Preliminary evidence indicates dose modification may be unnecessary. However, physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Starcad-Beta 25 Extended-Release tablets cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Starcad-Beta 25 Tablet ER :
NA
Facts to Know About Starcad-Beta 25 Tablet ER
| Label | Value |
|---|---|
| Chemical Classification | Alcohols and Phenols |
| Developing Habits | No. |
| Type of Therapy | Heart |
| Action Class | Cardioselective beta-blocker |
3,018 People bought this recently